← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2004Last known activity
Dec 15, 2021
Timeline
2000s
- Feb 1, 2004
Nordic Lymphoma Group— Founded
Drugs by trial phase (26 distinct, 18 trials)
Phase 3 (17 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Indications
Recent trials (20)
- NCT05214183Lead sponsorPhase 2Dec 15, 2021
- NCT04639362CollaboratorPhase 2Dec 29, 2020
- NCT04332822Lead sponsorPhase 3Mar 31, 2020
- NCT03505944Lead sponsorPhase 1/Phase 2Jun 1, 2018
- NCT03293173Lead sponsorPhase 2Aug 4, 2017
- NCT03576443Lead sponsorPhase 2Jul 7, 2017
- NCT02451111CollaboratorPhase 2Oct 1, 2015
- NCT02460276CollaboratorPhase 2Apr 1, 2015
- NCT01325194Lead sponsorPhase 2Mar 1, 2011
- NCT00725231CollaboratorPhase 3Feb 1, 2008
- NCT00514475Overall official - principal investigatorPhase 2Nov 1, 2005
- NCT00514475Study chairPhase 2Nov 1, 2005
- NCT01502982Lead sponsorPhase 2Nov 1, 2004
- NCT00209209CollaboratorPhase 3Jan 14, 2004
- NCT01609010CollaboratorPhase 3Oct 1, 2002
Details
- Founded
- Aarhus, DK Feb 1, 2004
- Last known activity
- Dec 15, 2021